MINI FUTURE SHORT - DIASORIN Stock

Certificat

P1K1C3

NLBNPIT1K1C3

Market Closed - Borsa Italiana 11:30:00 2022-12-14 EST
11.48 ^EUR	-20.88%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart DIASORIN S.P.A.

Latest news about DIASORIN S.P.A.

Citadel Advisors moves on Saipem and Biesse.	10:04am	AN
DiaSorin takes over shares for more than EUR8 million	05-20	AN
Ex-dividend day for final dividend	05-19	FA
DiaSorin receives clearance from US FDA for NxTAG panel	05-17	AN

More news

Static data

Product type	Knock-Out with Stop Loss
Buy / Sell	PUT
Underlying	DIASORIN S.P.A.
Issuer	BNP Paribas
	P1K1C3
ISIN	NLBNPIT1K1C3
Date issued	2022-11-16
Strike	150.6 €
Maturity	2025-12-19 (577 Days)
Parity	1 : 1
Emission price	- €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	23.17 €
Lowest since issue	11.48 €
Spread	0.5 €
Spread %	4.28%

Company Profile

DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc. At the end of 2023, the group had 10 production sites located in Italy, the United States (6), Canada, Germany, and the United Kingdom.

Sector

More about the company